1. Home
  2. BRNS vs ZGM Comparison

BRNS vs ZGM Comparison

Compare BRNS & ZGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRNS
  • ZGM
  • Stock Information
  • Founded
  • BRNS 2016
  • ZGM 2019
  • Country
  • BRNS United Kingdom
  • ZGM Macau
  • Employees
  • BRNS N/A
  • ZGM N/A
  • Industry
  • BRNS Biotechnology: Pharmaceutical Preparations
  • ZGM Professional Services
  • Sector
  • BRNS Health Care
  • ZGM Consumer Discretionary
  • Exchange
  • BRNS Nasdaq
  • ZGM Nasdaq
  • Market Cap
  • BRNS 48.3M
  • ZGM 47.4M
  • IPO Year
  • BRNS 2021
  • ZGM 2025
  • Fundamental
  • Price
  • BRNS $1.05
  • ZGM N/A
  • Analyst Decision
  • BRNS Strong Buy
  • ZGM
  • Analyst Count
  • BRNS 1
  • ZGM 0
  • Target Price
  • BRNS $3.00
  • ZGM N/A
  • AVG Volume (30 Days)
  • BRNS 37.7K
  • ZGM 1.3M
  • Earning Date
  • BRNS 11-05-2025
  • ZGM 01-01-0001
  • Dividend Yield
  • BRNS N/A
  • ZGM N/A
  • EPS Growth
  • BRNS N/A
  • ZGM 401.52
  • EPS
  • BRNS N/A
  • ZGM 0.17
  • Revenue
  • BRNS $14,969,000.00
  • ZGM $3,620,780.00
  • Revenue This Year
  • BRNS N/A
  • ZGM N/A
  • Revenue Next Year
  • BRNS N/A
  • ZGM N/A
  • P/E Ratio
  • BRNS N/A
  • ZGM $23.62
  • Revenue Growth
  • BRNS 1766.46
  • ZGM 211.78
  • 52 Week Low
  • BRNS $0.64
  • ZGM $2.00
  • 52 Week High
  • BRNS $2.92
  • ZGM $4.51
  • Technical
  • Relative Strength Index (RSI)
  • BRNS 40.11
  • ZGM N/A
  • Support Level
  • BRNS $1.08
  • ZGM N/A
  • Resistance Level
  • BRNS $1.20
  • ZGM N/A
  • Average True Range (ATR)
  • BRNS 0.09
  • ZGM 0.00
  • MACD
  • BRNS -0.01
  • ZGM 0.00
  • Stochastic Oscillator
  • BRNS 0.00
  • ZGM 0.00

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Share on Social Networks: